Currently working with consultants to develop trial protocols for a Phase I/II trial for the use of RPI–78M in the treatment of Pediatric Multiple Sclerosis. We expect to begin the trial in FY2017. Quarterly Report (10-q) http://ih.advfn.com/p.php?pid=nmona&article=75445391